Nonalcoholic Steatohepatitis Therapeutics Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The report also provides important recommendations for market<br />
players and new entrants. These recommendations would enable<br />
existing market players to expand their market shares and help<br />
new companies to establish their presence in the NASH market<br />
across different regions worldwide. The report concludes with<br />
the company profiles section, which includes key information<br />
about major players in the market such as financial overview,<br />
business strategies, and recent developments.<br />
Major players in this market are Astazeneca Plc (U.K.), Intercept<br />
Pharmaceuticals Inc. (U.S.), Galmed Pharmaceuticals Ltd.<br />
(Israel), GENFIT SA (France), Gilead Sciences, Inc. (U.S.),<br />
Zydus Cadila (India), Immuron Ltd. (Australia), Conatus<br />
Pharmaceuticals (U.S.), and Tobira <strong>Therapeutics</strong>, Inc. (U.S.).<br />
Browse Full Press Release on <strong>Nonalcoholic</strong> <strong>Steatohepatitis</strong><br />
<strong>Therapeutics</strong> <strong>Market</strong>:<br />
Press Release<br />
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market<br />
intelligence company providing business information reports<br />
and services. The company’s exclusive blend of quantitative<br />
forecasting and trend analysis provides forward-looking insight<br />
for thousands of decision makers. TMR’s experienced team of
Change language